Literature DB >> 2215605

Spinal bone loss and ovulatory disturbances.

J C Prior1, Y M Vigna, M T Schechter, A E Burgess.   

Abstract

BACKGROUND: Osteoporosis develops in women with estrogen deficiency and amenorrhea who lose bone at an accelerated rate. It is not known to what extent bone loss differs between ovulatory women with regular menstrual cycles who are training intensely and those who are sedentary.
METHODS: We measured the density of cancellous spinal bone from the 12th thoracic vertebra to the 3rd lumbar vertebra by quantitative computed tomography on two occasions one year apart in 66 premenopausal women 21 to 42 years of age. All the women had two consecutive ovulatory cycles immediately before entering the study. Twenty-one women were training for a marathon, 22 ran regularly but less intensively, and 23 had normal levels of activity. The lengths of the women's menstrual cycles and luteal phases, diet, exercise levels, and hormonal levels were also determined. We defined ovulatory disturbances as anovulatory cycles and cycles with short luteal phases.
RESULTS: The mean (+/- SD) spinal bone density in the 66 women decreased 3.0 +/- 4.8 mg per cubic centimeter per year (2.0 percent per year) (P less than 0.001). Amenorrhea did not develop in any woman during the year of observation (only 2.7 percent of the cycles were greater than 36 days long). Ovulatory disturbances occurred in 29 percent of all cycles, however. Bone loss was strongly associated with these disturbances (r = 0.54, 24 percent of the variance). The 13 women who had anovulatory cycles lost bone mineral at a rate of 6.4 +/- 3.8 mg per cubic centimeter per year (4.2 percent per year). The women training for a marathon had menstrual cycles similar to those of the women in the other two groups.
CONCLUSION: Decreases in spinal bone density among women with differing exercise habits correlated with asymptomatic disturbances of ovulation (without amenorrhea) and not with physical activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2215605     DOI: 10.1056/NEJM199011013231801

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  70 in total

Review 1.  Estrogen replacement therapy and female athletes: current issues.

Authors:  D C Cumming; C E Cumming
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

2.  Estrogen status and heredity are major determinants of premenopausal bone mass.

Authors:  R Armamento-Villareal; D T Villareal; L V Avioli; R Civitelli
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

3.  Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry.

Authors:  Micol S Rothman; Nichole E Carlson; Mei Xu; Christina Wang; Ronald Swerdloff; Paul Lee; Victor H H Goh; E Chester Ridgway; Margaret E Wierman
Journal:  Steroids       Date:  2010-11-09       Impact factor: 2.668

4.  Prospective decrease in progesterone concentrations in female lightweight rowers during the competition season compared with the off season: a controlled study examining weight loss and intensive exercise.

Authors:  F L Morris; W R Payne; J D Wark
Journal:  Br J Sports Med       Date:  1999-12       Impact factor: 13.800

Review 5.  Low Energy Availability in Exercising Women: Historical Perspectives and Future Directions.

Authors:  Joanne Slater; Rachel Brown; Rebecca McLay-Cooke; Katherine Black
Journal:  Sports Med       Date:  2017-02       Impact factor: 11.136

6.  Contributions of chronological age, age at menarche and menopause and of anthropometric parameters to axial and peripheral bone densities.

Authors:  L Vico; B Prallet; D Chappard; B Pallot-Prades; R Pupier; C Alexandre
Journal:  Osteoporos Int       Date:  1992-05       Impact factor: 4.507

Review 7.  Epidemiology of endocrine-related risk factors for breast cancer.

Authors:  Leslie Bernstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

8.  Establishment of BMD reference plots and determination of peak BMD at multiple skeletal regions in mainland Chinese women and the diagnosis of osteoporosis.

Authors:  Xian-Ping Wu; Er-Yuan Liao; Hong Zhang; Peng-Fei Shan; Xing-Zhi Cao; Shi-Ping Liu
Journal:  Osteoporos Int       Date:  2003-11-04       Impact factor: 4.507

9.  Comparison of the treatment effects of ossein-hydroxyapatite compound and calcium carbonate in osteoporotic females.

Authors:  P Rüegsegger; A Keller; M A Dambacher
Journal:  Osteoporos Int       Date:  1995-01       Impact factor: 4.507

Review 10.  Contraceptive hormone use and cardiovascular disease.

Authors:  Chrisandra L Shufelt; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2009-01-20       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.